The cost reduction in hospitalization associated with paliperidone palmitate in the People’s Republic of China Korea and Malaysia

摘要

BackgroundSchizophrenia results in substantial health care utilization costs. Much of these costs can be attributed to health care use resulting from nonadherence to treatment, relapse, and hospitalization.